Navigation Links
MiMedx to Present at Jefferies 2013 Global Healthcare Conference
Date:5/28/2013

KENNESAW, Ga., May 28, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Jefferies 2013 Global Healthcare Conference in New York.  Parker H. "Pete" Petit, Chairman and CEO and Michael J. Senken , Chief Financial Officer, are scheduled to present on June 3, 2013 at 1:30 p.m. Eastern Daylight Time. A webcast of this presentation will be available on the Company's website, www.mimedx.com

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 150,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.


'/>"/>
SOURCE MiMedx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
2. MiMedx Announces Record First Quarter 2013 Results
3. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
4. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
5. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
6. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
7. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
8. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
9. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
10. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
11. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017  Applied BioMath ( www.appliedbiomath.com ), ... drug research and development, today announced an ... for quantitative systems pharmacology (QSP) support for ... treatment of cancer. Applied ... toxicology studies and first-in-human dose predictions for ...
(Date:3/29/2017)... ... March 29, 2017 , ... Cancer diagnostics and pathology ... 513 at the Association of Community Cancer Centers (ACCC) 43rd Annual Meeting, ... CANCERSCAPE unites key stakeholders from leading national organizations to share insights on how ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - The University of ... Nordion, a business of Sterigenics International, and General Atomics ... been submitted to the U.S. Nuclear Regulatory Commission (NRC). ... production of molybdenum-99 (Mo-99). Once operational, production from this ... U.S. demand for Mo-99, which currently must be imported ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... American Association for the Advancement of Science (AAAS), the world's largest general ... will enhance its high-impact scholarly collection across its cross-platform reference management system. ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)... 28, 2017 News solutions for biometrics, bag ... ... from 14 to 16 March, Materna will present its complete ... seamless travel is a real benefit for passengers. To accelerate ... their passenger touch point solutions to take passengers through the complete ...
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
Breaking Biology News(10 mins):